I Boccon-Gibod

Summary

Affiliation: CHU de Grenoble
Country: France

Publications

  1. doi [Hereditary angioedema: Treatment and educational therapeutic program]
    Isabelle Boccon-Gibod
    CHU de Grenoble, Clinique Universitaire de Médecine Interne, centre de référence national de l angioedème, BP 217, 38043 Grenoble Cedex 09, France Electronic address
    Presse Med 44:78-88. 2015
  2. doi [Angioedema and urticaria]
    I Boccon-Gibod
    Centre national de référence des angioedèmes CREAK, CHU de Grenoble, Hopital Nord, Boulevard de la Chantourne, 38700 La Tronche, France Clinique universitaire de médecine interne, Pôle Pluridisciplinaire de Médecine, CHU de Grenoble Hôpital Albert Michallon, BP 217, Boulevard de la Chantourne, 38043 Grenoble Cedex 9, France Electronic address
    Ann Dermatol Venereol 141:S586-95. 2014
  3. pmc Safety and efficacy of icatibant self-administration for acute hereditary angioedema
    I Boccon-Gibod
    National Reference Center for Angioedema CREAK, Department of Internal Medicine, Grenoble University Hospital, Grenoble, France
    Clin Exp Immunol 168:303-7. 2012
  4. doi [Bradykinin mediated angioedema]
    L Bouillet
    Centre de référence sur les angiœdèmes bradykiniques CREAK, Clinique Universitaire de Médecine Interne, BP 217, 38043 Grenoble Cedex 09, France
    Rev Med Interne 32:225-31. 2011
  5. doi Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients
    C Wintenberger
    Department of Internal Medicine, University Hospital, Grenoble, France
    Clin Exp Immunol 178:112-7. 2014

Collaborators

  • L Bouillet
  • C Wintenberger
  • A Gompel
  • L Martin
  • O Fain
  • P Y Jeandel
  • G Kanny
  • D Launay

Detail Information

Publications5

  1. doi [Hereditary angioedema: Treatment and educational therapeutic program]
    Isabelle Boccon-Gibod
    CHU de Grenoble, Clinique Universitaire de Médecine Interne, centre de référence national de l angioedème, BP 217, 38043 Grenoble Cedex 09, France Electronic address
    Presse Med 44:78-88. 2015
    ..CREAK protocols are available. The HAE National Educational Therapeutic Program "Educreak" is in place to allow the patient and his close family or partners to acquire skills for greater autonomy in day to day disease management. ..
  2. doi [Angioedema and urticaria]
    I Boccon-Gibod
    Centre national de référence des angioedèmes CREAK, CHU de Grenoble, Hopital Nord, Boulevard de la Chantourne, 38700 La Tronche, France Clinique universitaire de médecine interne, Pôle Pluridisciplinaire de Médecine, CHU de Grenoble Hôpital Albert Michallon, BP 217, Boulevard de la Chantourne, 38043 Grenoble Cedex 9, France Electronic address
    Ann Dermatol Venereol 141:S586-95. 2014
    ..In chronic urticaria, steroids should be avoided : they can make symptoms worse and long-lasting because of corticosteroid dependence. ..
  3. pmc Safety and efficacy of icatibant self-administration for acute hereditary angioedema
    I Boccon-Gibod
    National Reference Center for Angioedema CREAK, Department of Internal Medicine, Grenoble University Hospital, Grenoble, France
    Clin Exp Immunol 168:303-7. 2012
    ..The only adverse events were mild, spontaneously resolving injection site reactions. Patients reported that carrying icatibant with them gave them greater confidence in managing their condition...
  4. doi [Bradykinin mediated angioedema]
    L Bouillet
    Centre de référence sur les angiœdèmes bradykiniques CREAK, Clinique Universitaire de Médecine Interne, BP 217, 38043 Grenoble Cedex 09, France
    Rev Med Interne 32:225-31. 2011
    ..In case of severe attacks, icatibant (bradykinin receptor antagonist) or C1 inhibitor concentrate can be used. In case of frequent attacks, long-term therapy with danazol or tranexamic acid is effective...
  5. doi Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients
    C Wintenberger
    Department of Internal Medicine, University Hospital, Grenoble, France
    Clin Exp Immunol 178:112-7. 2014
    ..Thus, TA, which is well tolerated and inexpensive, appears to be an effective maintenance treatment for some patients with HAE or idiopathic non-histaminergic AE...